The arrival of the drug Retatrutide at a 20mg dosage is generating considerable excitement within the medical world. This innovative dual-action GIP and GLP-1 mimetic demonstrates impressive efficacy in clinical trials, potentially offering a more effective approach to tackling excess weight . Early